Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1975 Jun;2(3):223–226. doi: 10.1111/j.1365-2125.1975.tb01579.x

A clinical and psychometric evaluation of flurazepam.

M R Salkind, T Silverstone
PMCID: PMC1402587  PMID: 10943

Abstract

1 The efficacy of flurazepam (15 mg or 30 mg) as a hypnotic, and the residual effects of each dose were compared with placebo in a double-blind cross-over trial involving thirty patients in a general practice setting. Patients received each medication for one week. Daily self-ratings of onset, duration and quality of sleep, together with reports of any untoward effects were made. At the end of each period of medication psychomotor tests (reaction time, pursuit rotor, tapping speed) were administered at 09.00 hours. 2 Both doses of flurazepam were significantly more effective than placebo in inducing sleep, improving the quality of sleep and extending its duration. 3 'Hangover' effects were marked following 30 mg, but not after flurazepam (15 mg). Flurazepam (30 mg, but not 15 mg) significantly impaired performance on the pursuit rotor test and tapping speed. Flurazepam thus appears to be an effective hypnotic drug with the optimum dose for use in general practice being 15 mg at night.

Full text

PDF
223

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bond A. J., Lader M. H. The residual effects of flurazepam. Psychopharmacologia. 1973 Sep 28;32(3):223–235. doi: 10.1007/BF00422145. [DOI] [PubMed] [Google Scholar]
  2. Hartmann E. The effect of four drugs on sleep patterns in man. Psychopharmacologia. 1968;12(4):346–353. doi: 10.1007/BF00401413. [DOI] [PubMed] [Google Scholar]
  3. Jick H. Comparative studies with a hypnotic (RO 5-6901) under current investigation. Curr Ther Res Clin Exp. 1967 Jul;9(7):355–357. [PubMed] [Google Scholar]
  4. Kales A., Kales J. D. Sleep laboratory evaluation of psychoactive drugs. Pharmacol Physicians. 1970 Sep;4(9):1–6. [PubMed] [Google Scholar]
  5. Sambrooks J. E., MacCulloch M. J., Birtles C. J., Smallman C. Assessment of the effects of flurazepam and nitrazepam on visuo-motor performance using an automated assessment technique. Acta Psychiatr Scand. 1972;48(5):443–454. doi: 10.1111/j.1600-0447.1972.tb04387.x. [DOI] [PubMed] [Google Scholar]
  6. Tansella M., Zimmermann-Tansella C., Lader M. The residual effects of N-desmethyldiazepam in patients. Psychopharmacologia. 1974;38(1):81–90. doi: 10.1007/BF00421290. [DOI] [PubMed] [Google Scholar]
  7. Zimmerman A. M. Comparative effects of flurazepam hydrochloride (dalmane) and placebo in patients with insomnia. Curr Ther Res Clin Exp. 1971 Jan;13(1):18–22. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES